Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Lymphoma Diagnosis and Treatment, and Viral-associated cancers and disorders.
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning
Dynamics and durability of HIV-1 neutralization are determined by viral replication
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation
Swarm Learning for decentralized and confidential clinical machine learning
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)